Skip to main content

Genetics

CRISPR 2.0: Genome engineering made easy as A-B-C

CRISPR 2.0 is causing quite the ruckus in the scientific community. Why? Imagine that you had written a note in permanent marker, but later decided you wanted to change a single word. Without the ability to erase, your options would be limited, and…

Catching Cancer: Blood Test for Early-Stage Diagnosis

What is the difference between a normal cell and a cancer cell? The answer lies in their DNA. Cancer results from the accumulation of genetic mutations, which trigger uncontrolled cell growth. Cancer’s mutated DNA can reveal its presence early on in…

Moon and Stars

If you look closely at this zebrafish embryo, you will notice bright spots that look like stars covering the entire body. The nuclei of each cell in this embryo has been labeled with a fluorescent protein so when you look at the nuclei under a…

Min Ya

My name is Min Ya, or Ya Min, but I go by Minya. I was born and raised in China. Heavily influenced by my botany-enthusiast father, I have been a plant lover since I was very little. Before grad school, I finished my undergrad in China and Japan, and…

Could Woolly Mammoths Walk Again?

The Church lab at Harvard University recently announced plans to create a hybrid mammoth and elephant. Using a technology called CRISPR, researchers in the Church lab have learned how to insert mammoth DNA into the cells of modern elephants.…

Genetic Evidence Exonerates HIV’s “Patient Zero”

High-resolution microscope image of an immune cell infected with HIV [Image: ‘HIV-infected T Cell’ from NIAID]Gaeten Dugas, the man who received the title “Patient Zero” for supposedly bringing HIV/AIDS into the United States, has been…

Shrink to grow: on the road towards a 57-codon bacterium

“Shrink to grow” is a two-pronged business strategy where a company gets rid of unprofitable brands (“shrink”) to focus its resources on a few remaining or new brands (“grow”). Companies like P&G and Microsoft have used it, and a similar idea to…